Strength
600 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722004412
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
ZILEUTONApproval Type
Generic (ANDA)
FDA Application
ANDA215742On Market Since
10/11/2022
Pharmacological Classes
5-Lipoxygenase Inhibitor
5-Lipoxygenase Inhibitors
Decreased Leukotriene Production
Related Drugs
Same classification